(19)
(11) EP 0 915 879 A1

(12)

(43) Date of publication:
19.05.1999 Bulletin 1999/20

(21) Application number: 97933939.0

(22) Date of filing: 04.07.1997
(51) International Patent Classification (IPC): 
C07D( . )
A61K 31/ 517( . )
A61P 29/ 00( . )
C07D 215/ 20( . )
C07D 239/ 70( . )
C07D 487/ 04( . )
C07D 491/ 052( . )
 A61K 31/ 47( . )
A61K 31/ 519( . )
A61P 37/ 08( . )
C07D 217/ 24( . )
C07D 471/ 04( . )
C07D 491/ 04( . )
(86) International application number:
PCT/SE1997/001219
(87) International publication number:
WO 1998/001449 (15.01.1998 Gazette 1998/02)
(84) Designated Contracting States:
AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
LT LV RO SI

(30) Priority: 09.07.1996 GB 19960014360
24.12.1996 GB 19960026884

(71) Applicant: Astra Pharmaceuticals Limited
Kings Langley, Herts WD4 8DH (GB)

(72) Inventors:
  • BANTICK, John
    Burton-on-the-Wolds, Leics LE12 5HG (GB)
  • PERRY, Matthew
    Loughborough, Leics LE11 4SL (GB)
  • THORNE, Philip
    Loughborough, Leics LE11 2LE (GB)

(74) Representative: As Sivborg, Susanne Birgitta, et al 
Astra AB, Intellectual Property, Patents
151 85 Södertälje
151 85 Södertälje (SE)

   


(54) NOVEL COMPOUNDS